CoreAge Rx GLP-1 · Compounded semaglutide (injection)

Medication paths

Reported starting figures: compounded semaglutide from $99/mo and compounded tirzepatide from $149/mo, explicitly named in separate homepage product sections and corroborated by their individual product pages. These are not established monthly-billed charges. The same homepage also says the combined GLP-1 offering is from $199/mo; that discrepancy is unresolved. The home35 landing page's starting prices are expressly based on a 12-month plan paid in full, as quoted in first_month_price. Its broad $149 flat-rate claim is not applied to every medication. Exact selected-plan recurring charge, renewal cadence and all-in price remain UNKNOWN. No efficacy claim in the source excerpt is adopted. Reported information: offers are limited to United States residents aged 18 and older. Prescription products require consultation and a valid prescription; individual treatment eligibility is a clinician decision, not established by age alone. A treatment-specific BMI threshold is UNKNOWN in the captured public pages.

Insurance

No insurance billing claim was found on the captured page; verify payment options directly.

Consultation or membership

UNKNOWN exact fee for the selected GLP-1 treatment; not zero. The refund policy reports a possible $50–$100 consultation fee depending on the treatment purchased and says it is non-refundable once consultation or medical review begins. This is a conditional provider-reported range, not a universal additional charge or a confirmed first-order amount.

Shipping or timing

Reported information: medication typically arrives approximately 2–3 business days after pharmacy shipment. This is carrier transit, not time from checkout to arrival. Medical review, documentation, approval and compounding occur before shipment, so end-to-end arrival time remains UNKNOWN. Standard prescription shipping is included unless otherwise disclosed at checkout; no unconditional zero shipping charge is inferred.

Cancellation

Reported information, not a legal determination: the policy allows cancellation through the patient account or Patient Care Team before renewal is processed to stop future charges; this does not automatically cancel or refund processed orders. It also describes one-time purchases and automatic-renewal subscriptions, so no universal no-subscription claim is made. Order cancellation is conditional on no provider approval, no pharmacy transmission and remaining within the policy's refund window. Applicable consultation fees may be retained. The policy says prescription orders are final after both approval and pharmacy transmission, and establishes a 30-calendar-day order refund cutoff subject to applicable law. Canceling future renewals remains distinct from refunding the current order.

State evidence

United States offer; Katalys program terms restrict Louisiana and Mississippi.